PROTAC AR Degrader-4 TFA liquiritigenin Ledipasvir/Sofosbuvir administration achieves very high

Ledipasvir/Sofosbuvir administration achieves very high rate of viral clearance in patients with HCV genotype 1 infection without cirrhosis

1620401-82-2

C[C@@H](N)C1CCC(CC1)C(=O)NC1C=CN=CC=1

is an ATM inhibitor and ATR inhibitor

Teschemacher AG

PROTAC AR Degrader-4 TFA liquiritigenin Ledipasvir/Sofosbuvir administration achieves very highPROTAC AR Degrader 4 comprises a cIAP1 ligand binding group, a linker and an androgen receptor (AR) binding group. PROTAC AR Degrader 4 is an AR degrader. Degradation inducers based on cIAP1 are called specific and non genetic IAP dependent protein erasers (SNIPERs) Product information Molecular Weight: 884. 03 Formula: C45H68F3N3O11 Chemical Name: (1S,3aS,3bR,5aS,9aS,9bS,11aS) 9a,11a dimethyl 7 oxo hexadecahydro 1H cyclopenta[a]phenanthren 1 yl 2 [2